Results 131 to 140 of about 8,927 (183)

Upadacitinib for atopic dermatitis induced by secukinumab in patients with refractory ankylosing spondylitis:a case report. [PDF]

Front Immunol
Fang J, Pan S.
europepmc   +1 more source

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.

JAMA Dermatol
Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB.   +11 more
europepmc   +1 more source

Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors. [PDF]

Clinicoecon Outcomes Res
Permsuwan U, Dilokthornsakul P, Sawangjit R.   +2 more
europepmc   +1 more source

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

J Clin Endocrinol Metab
Wolf J, Lorenz K, Othman AE, Beck A, Michel HM, Grauhan L, Elflein H, Luffy M, Eckstein A, Lahner H, Schittkowski M, Horn M, Lagrèze WA, Bleul T, Pitz S, Vorländer C, Pieterse CC, Porter B, Clemens A, Draikiwicz S, Reinhardt M, Kahaly GJ.   +21 more
europepmc   +1 more source

Transcriptomic profiling of secukinumab-treated psoriatic arthritis reveals potential novel response-associated pathways. [PDF]

Rheumatology (Oxford)
Abdul Jalil NA, Chinoy H, Jani M, Barton A, Thompson C, Martin P, Nair N, Bluett J, Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) .   +8 more
europepmc   +1 more source

Dupilumab-Induced Psoriasiform Eruption in an 83-Year-Old Patient. [PDF]

Cureus
Pham VX, Gilbertson E.
europepmc   +1 more source

Using causal machine learning and real world data to improve dose response decision making for secukinumab in psoriatic arthritis. [PDF]

Sci Rep
Kiltz U, Glassen T, Brandt-Juergens J, Kiss F, Peterlik D, Gmeiner B.   +5 more
europepmc   +1 more source

Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up. [PDF]

Front Immunol
Nagler LK, Strunz PP, Labinsky H, Kroiß A, Gernert M, Schmalzing M.   +5 more
europepmc   +1 more source

Paradoxical Cutaneous Reaction: Secukinumab-Associated PLEVA in Palmoplantar Pustulosis. [PDF]

J Inflamm Res
Liu W, Chen Y, Lin Z, Zhang J, Li C.
europepmc   +1 more source

Vunakizumab for IL-17A-Mediated Diseases: A Review in Psoriasis and Spondyloarthritis. [PDF]

Biologics
Yan H, Chen Y, Song Y, Yan M, Yan K.
europepmc   +1 more source